Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2016
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infectionJ Stuart Elborn, Patrick A Flume, Fredric Cohen, et al.Journal of the Pediatric Infectious Diseases Society|September 26, 2015
In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis PatientsDonald R VanDevanter, Jill M Van Dalfsen, Jane L Burns, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 12, 2015
Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatmentDonald R VanDevanter, Jennifer S Kahle, Amy K O'Sullivan, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2016
BMI fails to identify poor nutritional status in stunted children with CFMichael W Konstan, David J Pasta, Jeffrey S Wagener, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 1, 2013
Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005Donald R VanDevanter, Eric P Elkin, David J Pasta, et al.Pediatric Pulmonology|January 12, 2021
Epidemiologic Study of Cystic Fibrosis: 25 years of observational researchMichael W Konstan, David J Pasta, Donald R VanDevanter, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2019
The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbationsJonathan D Cogen, Kathryn B Whitlock, Ronald L Gibson, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 14, 2003
Determination of polymyxin E1 in rat plasma by high-performance liquid chromatographyDennis J Gmur, Charles R Bredl, Sharon J Steele, et al.Pediatric Pulmonology|October 25, 2017
Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen changeDonald R VanDevanter, Marcia L Craib, David J Pasta, et al.Annals of the American Thoracic Society|November 16, 2017
Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary ExacerbationsMichael S Schechter, Donald R VanDevanter, David J Pasta, et al.Pageof 8